$SONO
Sonos Inc

2022 Q1 Form 10-Q Financial Statement

#000131472722000010 Filed on February 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $664.5M $645.6M
YoY Change 2.93% 268.7%
Cost Of Revenue $347.1M $346.2M
YoY Change 0.27% 239.08%
Gross Profit $317.4M $299.4M
YoY Change 6.0% 310.12%
Gross Profit Margin 47.76% 46.38%
Selling, General & Admin $123.5M $109.7M
YoY Change 12.55% 43.16%
% of Gross Profit 38.9% 36.64%
Research & Development $61.33M $52.35M
YoY Change 17.16% 5.55%
% of Gross Profit 19.32% 17.48%
Depreciation & Amortization $9.217M $7.982M
YoY Change 15.47% -17.71%
% of Gross Profit 2.9% 2.67%
Operating Expenses $184.8M $162.0M
YoY Change 14.04% 28.38%
Operating Profit $132.6M $137.4M
YoY Change -3.49% -358.21%
Interest Expense $98.00K $265.0K
YoY Change -63.02% -29.14%
% of Operating Profit 0.07% 0.19%
Other Income/Expense, Net -$1.467M $4.028M
YoY Change -136.42% -536.4%
Pretax Income $131.1M $141.4M
YoY Change -7.27% -361.25%
Income Tax $7.600M $9.100M
% Of Pretax Income 5.8% 6.44%
Net Earnings $123.5M $132.3M
YoY Change -6.66% -352.85%
Net Earnings / Revenue 18.58% 20.49%
Basic Earnings Per Share $0.97 $1.14
Diluted Earnings Per Share $0.87 $1.01
COMMON SHARES
Basic Shares Outstanding 127.7M shares 115.6M shares
Diluted Shares Outstanding 142.3M shares 130.6M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $754.4M $677.8M
YoY Change 11.3% 139.25%
Cash & Equivalents $754.4M $677.8M
Short-Term Investments
Other Short-Term Assets $22.53M $21.30M
YoY Change 5.78% -24.2%
Inventory $205.2M $88.19M
Prepaid Expenses
Receivables $178.3M $113.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.160B $900.9M
YoY Change 28.8% 94.15%
LONG-TERM ASSETS
Property, Plant & Equipment $69.00M $64.17M
YoY Change 7.52% -14.34%
Goodwill $37.73M $15.55M
YoY Change 142.69% 0.0%
Intangibles $29.86M $25.98M
YoY Change 14.96% -4.3%
Long-Term Investments
YoY Change
Other Assets $32.12M $16.90M
YoY Change 90.03% 635.92%
Total Long-Term Assets $212.4M $165.9M
YoY Change 27.98% -5.26%
TOTAL ASSETS
Total Short-Term Assets $1.160B $900.9M
Total Long-Term Assets $212.4M $165.9M
Total Assets $1.373B $1.067B
YoY Change 28.67% 66.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $341.3M $239.8M
YoY Change 42.37% 191.99%
Accrued Expenses $164.5M $96.43M
YoY Change 70.59% 124.05%
Deferred Revenue $17.82M $16.38M
YoY Change 8.76% 12.28%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $24.94M
YoY Change 199.26%
Total Short-Term Liabilities $599.3M $455.8M
YoY Change 31.49% 113.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $905.0K $3.726M
YoY Change -75.71% 39.24%
Total Long-Term Liabilities $905.0K $3.726M
YoY Change -75.71% -84.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $599.3M $455.8M
Total Long-Term Liabilities $905.0K $3.726M
Total Liabilities $693.1M $556.7M
YoY Change 24.52% 64.02%
SHAREHOLDERS EQUITY
Retained Earnings $53.58M -$96.20M
YoY Change -155.7% -49.35%
Common Stock $130.0K $121.0K
YoY Change 7.44% 7.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $54.88M $26.00M
YoY Change 111.03% -49.32%
Treasury Stock Shares
Shareholders Equity $679.6M $510.2M
YoY Change
Total Liabilities & Shareholders Equity $1.373B $1.067B
YoY Change 28.67% 66.91%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $123.5M $132.3M
YoY Change -6.66% -352.85%
Depreciation, Depletion And Amortization $9.217M $7.982M
YoY Change 15.47% -17.71%
Cash From Operating Activities $179.9M $214.5M
YoY Change -16.12% -357.21%
INVESTING ACTIVITIES
Capital Expenditures $6.355M $11.33M
YoY Change -43.92% -214.47%
Acquisitions $27.10M $0.00
YoY Change
Other Investing Activities -$27.10M $0.00
YoY Change -100.0%
Cash From Investing Activities -$33.46M -$11.33M
YoY Change 195.21% 6.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $31.37M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$30.94M $64.39M
YoY Change -148.06% -316.06%
NET CHANGE
Cash From Operating Activities $179.9M $214.5M
Cash From Investing Activities -$33.46M -$11.33M
Cash From Financing Activities -$30.94M $64.39M
Net Change In Cash $114.3M $270.7M
YoY Change -57.78% -318.69%
FREE CASH FLOW
Cash From Operating Activities $179.9M $214.5M
Capital Expenditures $6.355M $11.33M
Free Cash Flow $173.6M $203.2M
YoY Change -14.57% -376.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9892000 USD
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
614 Chapala Street
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001314727
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-01
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-01-01
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38603
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
SONOS, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0479476
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Barbara
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93101
CY2022Q1 dei City Area Code
CityAreaCode
805
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
965-3001
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
SONO
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127608612 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
754417000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
640101000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
185130000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
178257000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100779000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
205162000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22532000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31504000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1160368000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
957514000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68996000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71341000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33776000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33841000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
37726000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
15545000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29862000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24450000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10028000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32123000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26085000 USD
CY2022Q1 us-gaap Assets
Assets
1372743000 USD
CY2021Q4 us-gaap Assets
Assets
1138804000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
341343000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
214996000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
164501000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
108029000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28430000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77695000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17817000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35866000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47171000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39544000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
599262000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
476130000 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
54875000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
50276000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61330000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
53632000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32814000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33960000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57761000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2394000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2394000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
905000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3646000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
693136000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
569762000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
130000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
129000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
682504000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
690462000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53584000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69897000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1736000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1376000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
679607000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
569042000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1372743000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1138804000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
664481000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645584000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
347096000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
346159000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
317385000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
299425000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52346000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
83736000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
74453000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39725000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35242000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
184791000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
162041000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
132594000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
137384000 USD
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
33000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
36000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
98000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
265000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1402000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4257000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1467000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4028000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
131127000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
141412000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7646000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9120000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
123481000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
132292000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
123481000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
132292000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127662826 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115610523 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142322448 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130644147 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-360000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
847000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
123121000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
133139000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
569042000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13232000 USD
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
31365000 USD
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11882000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17459000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-360000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
679607000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
297839000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
69505000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5118000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14844000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
847000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
510209000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9217000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7982000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
17459000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14844000 USD
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1139000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1050000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-494000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1633000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
79000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
56650000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21800000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-93495000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4086000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7330000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
185127000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
33271000 USD
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-49094000 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15481000 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13510000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5633000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2321000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9128000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
179934000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
214513000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6355000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11333000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27101000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33456000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11333000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
929000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
31365000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13232000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
69505000 USD
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
11882000 USD
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
5118000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30944000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64387000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1218000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3174000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
114316000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
270741000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
640101000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
407291000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
754417000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
678032000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
23000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
166000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
413000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2672000 USD
CY2022Q1 sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
3410000 USD
CY2021Q1 sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
8102000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5499000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7814000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2246000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1509000 USD
CY2022Q1 sono Numberof Countries Where Products Distributed
NumberofCountriesWhereProductsDistributed
50 country
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates and judgments</span></div><div><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the outbreak of the novel coronavirus (COVID-19) was declared a pandemic. While the nature of the situation is dynamic, the Company has considered the impact when developing its estimates and assumptions noted above. Actual results and outcomes may differ from management's estimates and assumptions.</span></div>
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645584000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
664481000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645584000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
664481000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
664481000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645584000 USD
CY2022Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
203120000 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
121486000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1998000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1547000 USD
CY2022Q1 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
22865000 USD
CY2021Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
19160000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
178257000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100779000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4170000 USD
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
145492000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
154608000 USD
CY2022Q1 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
59670000 USD
CY2021Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
30522000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
205162000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
185130000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
15545000 USD
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
22181000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
37726000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13932000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4170000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9762000 USD
CY2022Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P2Y10M6D
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
34032000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29862000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2906000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3237000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3024000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
423000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
94000 USD
CY2022Q1 sono Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
78000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9762000 USD
CY2022Q1 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
27951000 USD
CY2021Q4 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
19989000 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
34292000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
16941000 USD
CY2022Q1 sono Accrued Inventory Current
AccruedInventoryCurrent
58871000 USD
CY2021Q4 sono Accrued Inventory Current
AccruedInventoryCurrent
37117000 USD
CY2022Q1 sono Accrued Manufacturing Logisticsand Product Development Current
AccruedManufacturingLogisticsandProductDevelopmentCurrent
21252000 USD
CY2021Q4 sono Accrued Manufacturing Logisticsand Product Development Current
AccruedManufacturingLogisticsandProductDevelopmentCurrent
14943000 USD
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
12649000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
13066000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9486000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5973000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
164501000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
108029000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
89498000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
62389000 USD
CY2022Q1 sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
23721000 USD
CY2021Q1 sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
3357000 USD
CY2022Q1 sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
9801000 USD
CY2021Q1 sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
9809000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
75578000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
68841000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13561000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
16175000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14103000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11782000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
19957000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
75578000 USD
CY2022Q1 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
22648000 USD
CY2021Q4 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
19266000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11268000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10724000 USD
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9666000 USD
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5604000 USD
CY2022Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3589000 USD
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3950000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47171000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39544000 USD
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5604000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3628000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5359000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6277000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1297000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3459000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9666000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6446000 USD
CY2022Q1 us-gaap Receivable For Recovery Of Import Duties Net
ReceivableForRecoveryOfImportDutiesNet
12300000 USD
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000.0 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1032249 shares
CY2022Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
1010286 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
31400000 USD
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
30.37
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
121500000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14545239 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.86
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
282141000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1076077 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.29
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12043 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.96
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13457119 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.91
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
227339000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
12395258 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.79
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
210785000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
13365802 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.90
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
225905000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9100000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17459000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14844000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7600000 USD
CY2022Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3200000 USD
CY2021Q1 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-10200000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
132292000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127662826 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115610523 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142322448 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130644147 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9479520 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22564357 shares
CY2022Q1 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
1900000 USD
CY2021Q1 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
1700000 USD

Files In Submission

Name View Source Status
0001314727-22-000010-index-headers.html Edgar Link pending
0001314727-22-000010-index.html Edgar Link pending
0001314727-22-000010.txt Edgar Link pending
0001314727-22-000010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q1fy22exhibit311ceo302.htm Edgar Link pending
q1fy22exhibit312cfo302.htm Edgar Link pending
q1fy22exhibit321ceo906.htm Edgar Link pending
q1fy22exhibit322cfo906.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sono-20220101.htm Edgar Link pending
sono-20220101.xsd Edgar Link pending
sono-20220101_cal.xml Edgar Link unprocessable
sono-20220101_def.xml Edgar Link unprocessable
sono-20220101_htm.xml Edgar Link completed
sono-20220101_lab.xml Edgar Link unprocessable
sono-20220101_pre.xml Edgar Link unprocessable